Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nerites, a marketer of new generation of synthetic biomaterials, has appointed Shaun Lonergan as its new CEO and a member of the board of directors.
Subscribe to our email newsletter
Most recently, Mr Lonergan served as vice president of sales, marketing, and business development for Ibis Biosciences.
Prior to Ibis, Mr Lonergan held similar executive positions at 454 Life Sciences, where he closed a $62 million distribution agreement with Roche Diagnostics, and NimbleGen Systems, which was acquired by Roche Diagnostics for $273 Million in 2007.
George Arida, chairman of the board of directors of Nerites, said: “We’re extremely pleased to welcome Shaun Lonergan as Nerites’s new CEO. Shaun has broad and deep experience in commercializing new technologies and driving growth. Bringing Shaun on board will drive future partnerships and position us well for upcoming clinical trials and product commercialization.”